These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10554472)

  • 1. The individual, the family, and genetic testing.
    Jacobs LA; Deatrick JA
    J Prof Nurs; 1999; 15(5):313-24. PubMed ID: 10554472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing and the family.
    Van Riper M
    J Midwifery Womens Health; 2005; 50(3):227-33. PubMed ID: 15895001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychological aspects of presymptomatic diagnosis in Huntington disease].
    Bondor B; Kárteszi J; Hadzsiev K; Kellermayer R; Melegh B; Kosztolányi G
    Orv Hetil; 2008 Mar; 149(13):609-12. PubMed ID: 18353742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early testing for Huntington disease in children: pros and cons.
    Toufexis M; Gieron-Korthals M
    J Child Neurol; 2010 Apr; 25(4):482-4. PubMed ID: 19808987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological effect of genetic testing for Huntington's disease: an update of the literature.
    Meiser B; Dunn S
    West J Med; 2001 May; 174(5):336-40. PubMed ID: 11342513
    [No Abstract]   [Full Text] [Related]  

  • 7. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
    Babul R; Adam S; Kremer B; Dufrasne S; Wiggins S; Huggins M; Theilmann J; Bloch M; Hayden MR
    JAMA; 1993 Nov; 270(19):2321-5. PubMed ID: 8230594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical dilemmas in testing for late onset conditions: reactions to testing and perceived impact on other family members.
    Chapman E
    J Genet Couns; 2002 Oct; 11(5):351-67. PubMed ID: 12625340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing of children for late onset disease.
    Sevick MA; Nativio DG; McConnell T
    Camb Q Healthc Ethics; 2005; 14(1):47-56. PubMed ID: 15747482
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethical issues and policy analysis for genetic testing: Huntington's disease as a paradigm for diseases with a late onset.
    Lilani A
    Hum Reprod Genet Ethics; 2005; 11(2):28-34. PubMed ID: 16270448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
    Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
    Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing for cancer predisposition and implications for nursing practice: narrative review.
    Bancroft EK
    J Adv Nurs; 2010 Apr; 66(4):710-37. PubMed ID: 20423360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive diagnostics in chorea huntington: psychotherapeutic implications for counselling].
    Richartz-Salzburger E; Mau-Holzmann U; Schott KJ; Buchkremer G
    Psychiatr Prax; 2006 Jul; 33(5):211-7. PubMed ID: 16802259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General practitioners and predictive genetic testing for late-onset diseases in Flanders: what are their opinions and do they want to be involved?
    Welkenhuysen M; Evers-Kiebooms G
    Community Genet; 2002; 5(2):128-37. PubMed ID: 12739519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychotherapy of genetics.
    McDaniel SH
    Fam Process; 2005 Mar; 44(1):25-44. PubMed ID: 15807076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing and mental health: the model of Huntington disease.
    Williams JK; Schutte DL
    Online J Issues Nurs; 2000; 5(3):3. PubMed ID: 11380269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presymptomatic testing for Huntington's disease. Emotional aspects.
    Zak JP; Zaglul JT; Mueller OT; Diamond T
    J Fla Med Assoc; 1994 Feb; 81(2):109-12. PubMed ID: 8169585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition testing for cancer: effects on families' lives.
    MacDonald DJ
    Holist Nurs Pract; 1998 Apr; 12(3):9-19. PubMed ID: 9624953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perception of predictive testing for Huntington's disease by young women: preferring uncertainty to certainty?
    Decruyenaere M; Evers-Kiebooms G; Van den Berghe H
    J Med Genet; 1993 Jul; 30(7):557-61. PubMed ID: 8411027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.